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Abstract
 .The amyloid precursor protein APP gene promoter contains a heat shock element. An abnormal APP heat shock
response could increase accumulation of Ab, the APP metabolite found in Alzheimer’s disease amyloid plaques. Since Ab
 .production is affected by presenilin-1 PS-1 mutations, we investigated whether basal APP levels or response to heat shock
were altered in lymphoblastoid cell lines from 8 PS-1 mutation-bearers and 9 control members of Alzheimer’s disease
families. Lymphoblastoid cell lines were incubated at 428C for 35 min and allowed to recover at 378C for 1, 3, 8, 24 and
48 h. APP mRNA levels, quantified using RNA–RNA solution hybridisation, increased significantly at 1 and 3 h post-heat
 .shock to between 123% and 163% of pre-heat shock 0 h levels and returned to normal by 8 h. Semi-quantitative Western
immunoblotting of cell lysates using the 22C11 antibody detected two major bands, migrating at f145 and f120 kDa.
Band optical densities increased significantly at 3 h to f155% of 0 h levels, following the increase in APP mRNA levels
and showing a similar reversibility. APP mRNA and protein responses were comparable in the PS-1 mutation-bearing and
control cell lines. This study shows that both APP mRNA and protein are induced in lymphoblastoid cell lines following
heat shock and that this response is not affected by PS-1 mutations which are pathogenic for Alzheimer’s disease. q 1997
Elsevier Science B.V.
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1. Introduction
Three genes carrying mutations which are
pathogenic for Alzheimer’s disease have recently been
identified, namely the amyloid precursor protein
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 .  .APP gene on chromosome 21, presenilin-1 PS-1
 .gene on chromosome 14 and presenilin-2 PS-2 gene
 w x.on chromosome 1 reviewed in 1 . A metabolite of
APP, Ab, is found aggregated in plaques, the abnor-
mal extracellular amyloid deposits which are typical
of Alzheimer’s disease neuropathology. Pathogenic
APP and PS mutations have been shown to increase
production of either total Ab or the less soluble,
more amyloidogenic form of this peptide, Ab .42r43
These effects have been observed in a variety of
studies of transfected cells, fibroblasts, plasma, post-
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mortem brains of mutation bearers and transgenic
mice expressing mutation-bearing human APP or PS
 w x.reviewed in 2 . Besides driving the pathology of
Alzheimer’s disease by providing the substrate for
plaque development, it is also possible that altered
APP processing compromises the normal functions of
APP. Investigation of the functions and fates of APP
and PS, and how these are affected by the presence of
pathogenic mutations, should improve understanding
of their roles in the aetiology of Alzheimer’s disease.
A number of different APP isoforms, arising from
alternative splicing of exons 7, 8 or 15, have been
identified. Exon 7 shows homology to a Kunitz type
 .protease inhibitor KPI and APP containing this
w xregion is expressed ubiquitously 3 . Exon 15-lacking
isoforms are expressed in immunocompetent cells
w xsuch as macrophages and leukocytes 4 , while
w xAPP695 which lacks exons 7 and 8 5 is primarily a
neuronal specific isoform.
The APP promoter resembles that of a housekeep-
ing gene and also contains potential transcription
factor recognition sites including AP-1, AP-2, AP-4
and SP-1, a heat shock element and methylation sites
w x6,7 . This indicates that APP expression can be
regulated by occupation of cell surface receptors
acting via several different signal transduction cas-
w x .cades 8,9 and references therein , as well as by
physical factors, such as heat. Heat shock transcrip-
tion factors bind heat shock elements on promoters
under a variety of conditions, including exposure to
ethanol, some heavy metals, viral infection and is-
chaemia as well as heat shock itself reviewed in
w x.10 . Heat shock increased APP expression in human
w x w xendothelial cells 11 , HeLa cells 12 and lym-
w xphoblastoid cell lines 13 and may also alter the
w xphosphorylation state 14 and cellular distribution of
w xAPP 15 . The significance of these findings is not
completely understood although it has been suggested
that APP or an APP metabolite may have a protective
w xfunction under stressful conditions 16 . The fact that
several of these responsive elements, including the
heat shock element, are conserved in the murine APP
w xpromoter 17 also indicates that the regulation of
APP expression is likely to serve an important
physiological function.
There is evidence that cerebral cortex affected by
Alzheimer’s disease is subjected to levels of stress
sufficient to induce a heat shock response. Increased
levels of various heat shock proteins have been de-
tected in the brains of individuals affected by this
w xdisease 18–20 at post-mortem. Although pre-mortem
 .fever may induce heat shock protein hsp 70 mRNA
w xin Alzheimer’s disease 21 , elevated hsp 72r73 and
hsx 70 expression in the disease did not correlate
w xwith agonal status 19,22 .
No consistent increase in APP mRNA expression
has been observed in Alzheimer’s disease post-
 w x. w xmortem brain reviewed in 23 24 , nor was any
effect on basal APP synthesis noted in fibroblasts
bearing PS-1 or PS-2 mutations, as compared to
w xcontrols 25 . However, fibroblasts derived from an
Alzheimer’s disease family carrying the PS-1 A246E
mutation have been reported to show a greater
stress-induced increase in APP mRNA transcription,
w xAPP and Ab levels than control cell lines 26 . A
slightly altered APP response to various types of
stress could predispose to Ab accumulation and the
formation of amyloid plaques in susceptible regions
of the brain over a period of decades.
In the present study, we used a cell culture system
to investigate the APP heat shock response in 8
affected and 9 non-affected members of early-onset
Alzheimer’s disease families. Lymphoblastoid cell
lines were established from members of BritishrIrish
families with mutations in the PS-1 gene, and unaf-
w xfected family members 27 . APP mRNA and protein
levels in the lymphoblastoid cell lines, determined
using quantitative solution hybridisation and semi-
quantitative Western immunoblotting respectively,
were assayed 0, 1, 3, 8, 24 and 48 h after a 35 min
heat shock treatment at 428C.
2. Materials and methods
2.1. Subjects
Lymphoblastoid cell lines were obtained from the
European Collection of Animal Cell Cultures Centre
for Applied Microbiology and Research, Porton
.Down, England . The subjects from whom the cell
lines were established are described in Table 1. All
cell lines were screened for PS-1 mutations by poly-
merase chain reaction amplification of cDNA fol-
lowed by single strand conformation polymorphism
analysis and direct sequencing C. Forsell, personal
. w xcommunication and see also 27 .
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2.2. Cell culture
Lymphoblastoids were cultured in RPMI medium
supplemented with 10% foetal bovine serum, 2 mM
L-glutamine, 100 unitsrml penicillin and 100 mgrml
streptomycin Gibco BRL, Life Technologies, Euro-
.pean Division . Cell culture media was changed 12 h
prior to heat shocking and the cells transferred to six
flasks, each with 60 ml cells. The flasks were re-
moved from the 378C incubator immediately prior to
heat shocking, the caps tightened and all except one
 .flask 0 h placed in a water bath at 428C for 35 min
without shaking. The 0 h cells were harvested by
 .centrifugation 1000=g, 5 min, 48C of 40 ml cells
 .  .for RNA and 20 ml cells for protein . Cell pellets
were snap frozen and stored at y708C. Following
heat shock, cells were allowed to recover at 378C for
1, 3, 8, 24 and 48 h before harvesting. Cell counts
were performed with trypan blue exclusion at all time
points. One cell line was also grown and harvested as
described without being heat shocked, as a control.
2.3. Preparation of total nucleic acid
 .Total nucleic acid TNA was prepared from the
 .frozen cell pellet Section 2.2 by homogenisation,
 .digestion with Proteinase K IBI, 200 mgrml and
subsequent extraction with phenolrchloroform, as
w xpreviously described 28 . The TNA pellet was dis-
solved in 200 ml 0.2=SET 0.2% SDS, 2 mM EDTA
.and 4 mM Tris, pH 7.6 and stored at y708C. TNA
and DNA concentrations were determined using spec-
trophotometry and Hoechst 33258 fluorimetry respec-
tively. RNA concentration was calculated by subtract-
ing the DNA from the TNA concentration.
2.4. Solution hybridisation-RNase protection assay
APP mRNA was quantified in all cell lines, and
levels of the APP homologue, amyloid precursor-like
 .protein-2 APLP2 mRNA were also determined in
some of the cell lines. These assays were carried out
w x 35as described in detail elsewhere 28 . Briefly, S-CTP
labelled antisense RNA probes termed total APP,
APP KPI and APLP2 were designed to hybridise to
 .human APP positions 99 to 207 ; exon 7 of APP; or
 .APLP2 positions 111 to 187 respectively. Antisense
probe was incubated with either increasing amounts
of unlabelled sense in vitro transcribed RNA, en-
abling construction of a standard curve; or with TNA
sample, for 18 h at 688C in the presence of 25%
formamide, 0.75 mM DTT, 0.6 M NaCl, 20 mM Tris
and 4 mM EDTA in a reaction volume of 40 ml,
covered with paraffin oil. Probes were selective for
their target mRNAs, as no signal was obtained fol-
lowing incubation with 150 pg of the corresponding
cDNA or inappropriate standards under the condi-
w xtions employed 28 . Following incubation with 1 ml
 .  .RNase T1 2 mgrml , RNase A 40 mgrml and
 .  .salmon sperm DNA 100 mgrml Sigma at 378C
for 45 min, ribonuclease-resistant hybrids were pre-
cipitated with 10% TCA, captured on Whatman
GFrC filters, and quantified by scintillation count-
ing. The amount of specific mRNA present was
Table 1
Lymphoblastoid cell lines
Family no. PS-1 mutation Exon Control subjects Mutation bearers
Cell line Age Cell line Age
F121 E120K 5 AC 056 39 AC 320 44
F148 M139V 5 AC 431 60 AC 187 50
F196 P267S 8 AC 137 39 AC 127 46
F196 P267S 8 y y AC 135 42
F168 E280G 8 AC 097 57 AC 111 58
F168 E280G 8 AC 096 49 AC 300 59
F74 Exon 9 splice AC 184 50 AC 041 42
F74 Exon 9 splice y y AC 025 52
F105 None y AC 456 58 y y
P0257 None y AC 347 52 y y
F278 None y AC 412 56 y y
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 .  .Fig. 2. The concentrations of RNA and DNA in the total nucleic acid TNA samples extracted from control a and PS-1
 .  .  .  .mutation-bearing b cell lines. Mean levels "SEM are shown for RNA dotted line , and DNA solid line prior to 0 h and 1, 3, 8, 24
and 48 h post heat shock. There were no differences between the amounts of TNA recovered from the mutation-bearing and control
lymphoblasts, however the DNArTNA ratio was significantly lower in the PS-1 mutation-bearing group at the 0, 1, 24 and 48 h time
 .points p-0.05, Mann–Whitney test .
calculated by comparison with the standard curve,
converted to the number of mRNA copies and ex-
pressed as a function of either the DNA or total RNA
w xcontent of the sample as previously described 28 .
2.5. Western immunoblotting
Cell lysates were immunoblotted with the mono-
clonal antibody 22C11 generously provided by Pro-
fessor K. Beyreuther, Center for Molecular Biology,
.Heidelberg , which recognises an APP N-terminal
 . w xepitope residues 66–81 29 . A polyclonal antibody
CT15, purchased from Dr. B.M. Austen, St. George’s
.Hospital Medical School, London raised against a
 .C-terminal epitope of APP residues 681–695 , was
used to confirm the identity of the bands detected by
w x22C11 30 . Fifteen mg cell lysate protein was sepa-
rated by 8% SDS polyacrylamide gel electrophoresis,
 .and transferred electrophoretically 200 V, 2 h to ni-
trocellulose membranes Schleicher and Schuell,
.0.45 mm . The membranes were blocked for 1 h in
 .20 mM Tris HCl pH 7.6 , 137 mM NaCl, and 0.1%
 .Tween 20 with 5% non-fat dried milk Carnation ,
 .then incubated for 3 h with 22C11 1:10000 or CT15
 .1:1000 and finally for 1 h with either HRP-linked
 .anti-mouse or anti-rabbit IgG Amersham, 1:2000
respectively. Immunoreactivity was visualised using
 .enhanced chemiluminescence Amersham and expo-
 .sure to Hyperfilm MP Amersham . Peak optical
densities of the bands were determined using Image
 .Master 1.D Pharmacia Biotech .
 .Fig. 1. Levels of APP mRNA detected in lymphoblastoid cell lines prior to 0 h and 1, 3, 8, 24 and 48 h post heat shock. The results of
 .  .  .assays using total APP probe a, c and APP KPI probe b, d are shown for the control open circles, ns9 and PS-1 mutation-bearing
 .  .  .filled circles, ns8 cell lines. Results are expressed as a function of total RNA a, b or DNA levels c, d in the samples. Solution
hybridisation assays were run 3 times for each individual and time point as described in Section 2.4 and the mean result"SEM presented
here. The levels of APP detected by both probes were significantly higher at 1 and 3 h post heat shock, compared to 0 h, in both the PS-1
 .mutation-bearing and control groups ) p-0.05, paired t-test . No significant differences were seen between the mutation-bearing and
control groups.
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3. Results
3.1. Cell ˝iability
There were no significant differences between the
viability of the PS-1 mutation-bearing and control
cell lines as assessed by trypan blue exclusion. At
 .0 h, the mean "SEM density of viable cells was
653 000"50 000 per ml in the control cell group,
 .83% of the total cell density mean 790 110 . In the
PS-1 mutation-bearing group, there were 686 300 "
56 000 viable cells per ml, 80% of total cell density
 .858 600 . Heat shock treatment did not reduce cell
viability and the density 48 h post-heat shock was
significantly higher than the cell density at 0 h, indi-
cating that the cells continued to divide. At 48 h, the
control group had 847 500"61 500 viable cells per
 .ml 85% of total and the PS-1 mutation group had
 .888 300"69 000 viable cells per ml 83% of total
 p-0.01, paired t-test for the comparisons with the
.respective 0 h .
3.2. Total APP and APP KPI mRNA le˝els in
lymphoblastoids
Approximately 95% of the total APP mRNA de-
tected at 0 h was also detected by the APP KPI probe,
indicating that virtually all of the APP mRNA present
 .in these cells contained the KPI insert Fig. 1 . No
significant differences were observed between the
levels of APP mRNA in the PS-1 mutation-bearing,
as compared to control cell lines. Fig. 1 shows that
the levels of APP mRNA detected in the PS-1 muta-
tion-bearing and control cell lines were very similar
when results were expressed as a function of DNA in
the sample, whereas the levels expressed as a func-
tion of total RNA in the sample were always lower in
the PS-1 mutation-bearing cell lines. This difference
was not statistically significant and reflected differ-
ences in the RNArDNA ratio in the PS-1 mutation-
 .bearing and control TNA samples see Section 3.4 .
3.3. Effect of heat shock on APP mRNA le˝els
The levels of APP mRNA detected by both probes
increased significantly 1 and 3 h post-heat shock Fig.
.1 to between 123 and 163% of the 0 h levels,
depending on whether the results were expressed as a
  .  ..function of sample DNA Fig. 1 c and d or total
  .  ..RNA content Fig. 1 a and b . This increase was
reversible, the levels returning to normal or below by
8 h post-heat shock. There were no significant differ-
ences between the extent or duration of the APP heat
shock response in the PS-1 mutation-bearing, as com-
pared to control cell lines. The levels of APP mRNA
did not increase in a control cell line, cultured and
harvested at the appropriate time points without the
heat shock treatment, the number of copies of total
Fig. 3. Western immunoblot of lymphoblastoid cell lysates using
 .  .  .  .22C11 a and b and CT15 b antibodies. Fig. 3 a shows the
 .bands detected by 22C11 in a control cell line prior to 0 h and
1, 3, 8, 24 and 48 h post heat shock treatment. 15mg protein was
separated by 8% SDS-PAGE, as described in Section 2.5. The
two most prominent immunoreactive bands migrated at f145
and f120kDa, with the f120kDa band sometimes appearing
as a doublet. Apparent molecular weights were determined by
comparison with a pre-stained molecular weight standard mixture
 .Sigma SDS-7B . The peak optical density of both bands in-
creased significantly 3 h post heat shock in both control and PS-1
 .mutation-bearing cell lines p-0.05, paired t-test . Fig. 3 shows
that the f145 and f120kDa bands detected by 22C11 were
also detected by the APP C-terminal polyclonal antibody, CT15.
Experiments were performed as described in Section 2.5 using
two 15mg protein samples from a control lymphoblastoid cell
line.
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APP mRNA per pg DNA at 1, 3 and 8 h being 102,
108 and 94% of the 0 h levels.
3.4. RNA:DNA ratio in samples
There were no significant differences between the
amounts of TNA recovered from the PS-1 mutation-
bearing and control lymphoblasts, both groups show-
ing a slightly higher recovery at 48 h compared to 0 h
due to the increased number of cells see Section
.  .3.1 . The TNA concentration mean"SD in control
samples increased from 2.36"0.44 mg TNArml at
0 h to 2.94"0.38 at 48 h, and from 2.46"0.76 to
3.29"0.59 mgrml in the PS-1 mutation group.
However, the proportions of total RNA and DNA in
these samples were different in the two study groups,
as shown in Fig. 2. The DNArTNA ratio was signifi-
cantly lower in the PS-1 mutation-bearing group at
the 0, 1, 24 and 48 h time points p-0.05, Mann–
.Whitney test , indicating a higher proportion of RNA
in the mutation-bearing cell lines. This difference did
not reflect altered cell viability in these cell lines see
.Section 3.1 .
3.5. Effect of heat shock on APP protein le˝els in cell
lysates
Two major immunoreactive bands, migrating at
approximately 145 and 120 kDa, were detected by
Western blotting of lymphoblastoid cell lysates, with
the f120 kDa band sometimes appearing as a dou-
  ..blet Fig. 3 a . We confirmed that both of these
bands corresponded to full length APP as they were
detected by both 22C11, directed against the N-
terminus, and CT15, directed against the C-terminus
 .of APP, as shown in Fig. 3 b .
Densitometric analysis of the f145 and f
120 kDa bands showed that the f145 kDa band was
slightly less intense than the f120 kDa band and the
 .ratio between them ca. 0.6:1 was not altered by heat
shock treatment. Samples from all time points for
each cell line were run on the same gel, and paired
comparisons made between the optical density at
each time point, and the optical density at 0 h. No
changes were observed in either band 1 h post-heat
shock, but the optical densities had increased for both
control and mutation-bearing cell lines by 3 h p-
Fig. 4. Levels of APP detected by Western immunoblotting of lymphoblastoid cell lysates. Peak optical densities of the f145 kDa APP
 .  .  .band a and f120 kDa band b are plotted as a percentage of the optical density at 0 h for control open circles, ns8 and PS-1
 .mutation-bearing filled circles, ns8 cell lines following heat shock. Mean values "SEM are shown. Experiments were performed as
described in Section 2.5 and samples from all time points in a particular cell line were run on the same gel. The optical density at each
 .time point was compared with the optical density at 0 h paired t-test , revealing significant increases in the f145 and f120 kDa bands
 .in both control and mutation-bearing cell lines 3 h post heat shock ) p-0.05, paired t-test . There were no significant differences
between PS-1 mutation-bearing and control cell lines in the degree or duration of the APP heat shock response.
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.0.05, paired t-test as shown in Fig. 4. The optical
density of the f145 kDa band had increased to
172% and to 157% of 0 h levels in control and PS-1
mutation-bearing cell lines respectively by 3 h post-
heat shock. The optical density of the f120 kDa
band had increased to 147% of 0 h levels in both
groups by 3 h post-heat shock. The levels of APP
detected reverted to basal values by 24 h post-heat
shock treatment. No significant differences were ob-
served between the PS-1 mutation-bearing and con-
trol groups in the degree or duration of the increase
in cell-associated APP following heat shock, ex-
pressed as a percentage of levels detected at 0 h. In
the control cell line, cultured and harvested without
heat shock treatment, the optical densities of the
f145 kDa bands at 1, 3 and 8 h were 132%, 92%
and 108% of the 0 h levels, while the f120 kDa
bands were 126%, 96%, and 77% of the 0 h levels.
4. Discussion
This study showed that the previously reported
increase in APP mRNA levels following heat shock
w xof lymphoblastoid cell lines 13 translates into in-
creased cell-associated APP protein. The effects of
increased temperature on APP expression are associ-
ated with an interaction between the heat shock ele-
ment on the APP promoter and an as yet unidentified
w xheat shock-inducible transcription factor 31 . Heat
shock has also been reported to affect APP levels in
w x w xHeLa cells 12 , PC-12 cells 14 and human endothe-
w xlial cells 11 , although the degree and time course of
the response varied in these cell lines.
No gross differences in the profiles of the APP
mRNA or protein responses to heat shock were ob-
served in cell lines derived from PS-1 mutation-
bearers, as compared to non-affected Alzheimer’s
disease family members. Cell survival was also simi-
lar following heat shock in both groups studied,
suggesting that the PS-1 mutations did not compro-
mise cell viability, at least following this type of
transient stress. Although the normal functions of
 .PS-1 or the mechanism s of action of the pathogenic
mutations in this gene are currently unknown, several
different PS-1 and -2 mutations have been shown to
increase production and deposition of Ab andror
w xAb both in vitro and in vivo 2 . The extent of42r43
this increase may vary depending on which PS-1
w xmutation is present 32 suggesting that the mutations
could affect PS-1 function, processing or interaction
with other proteins in different ways. Fibroblast cell
lines from members of the FAD1 pedigree PS-1
.A246E showed a greater increase in APP mRNA
transcription, APP and Ab levels than control cell
lines in response to stress induced by low serum
w xconditions 26 . This effect was not seen in fibrob-
w xlasts with the PS-1 M146L mutation 26 , while
fibroblasts bearing the PS-1 M146V, G209V, A246V,
L286V or PS-2 N141I mutations showed increased
Ab release in the absence of any effect on basal42r43
w xAPP synthesis 25 . The present study indicated that
the PS-1 E120K, M139V, P267S, E280G and exon 9
splice mutations did not affect basal or stress-induced
levels of APP. We did not see any gross differences
between cell lines with different PS-1 mutations,
although a detailed analysis of this issue would re-
quire the inclusion of more cell lines.
Previous studies of peripheral mononuclear blood
 .cells PBMC have not detected any Alzheimer’s
wdisease-related differences in APP mRNA levels 33–
x35 . Alterations in APP protein processing and levels
detected by Western immunoblotting have however
been reported in lymphoblastoid cell lines from indi-
w xviduals with familial Alzheimer’s disease 36 . Inves-
tigations of APP in PBMC using Western immuno-
blotting have, like the present study, described two
bands of immunoreactive material with apparent
wmolecular weights of between 90 and 140 kDa 4,35–
x38 . Pulse chase experiments in a T-lymphoid cell
line, H9, showed that a form of APP migrating at
105 kDa matured into a 140 kDa form, suggesting
that the difference in molecular weights between the
upper and lower bands is due to post-translational
modification, such as N- and O-linked glycosylation
w x29,39 . No PS-1 mutation or heat shock-related dif-
ferences in the relationship between the f145 and
f120 kDa bands were observed in the present study,
indicating that these factors did not affect the normal
maturation of APP in the lymphoblastoid cell lines.
In addition, there were no obvious differences be-
tween the levels of immunoreactivity detected in the
PS-1 mutation-bearing and control groups, although
comparison was difficult as the semi-quantitative na-
ture of Western immunoblotting meant that we only
compared samples run on the same gel.
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Since the monoclonal antibody 22C11 can cross-
 .react with amyloid precursor-like protein 2 APLP2
w x40 , we also assayed APLP2 mRNA in some of these
cell lines using solution hybridisation assay as de-
scribed in Section 2.4. APLP2 mRNA levels were
below the limit for reliable quantification by this
assay in samples of up to 40 mg total RNA, indicat-
ing that less than 0.3 APLP2 mRNA copies were
present per pg total RNA, or less than one fifth of the
APP mRNA level. This indicated that cross-reactivity
with APLP2 was unlikely to have contributed signifi-
cantly to the signal obtained by Western immuno-
blotting using 22C11.
The cell lines used in the present study were
generated by exposure of lymphocytes to Epstein
Barr virus, a human herpesvirus which transforms
resting human B-lymphocytes into dividing blast cells
w x41 . B-lymphocytes have been reported to express
w xAPP at lower levels than T-lymphocytes 4 . Using
quantitative solution hybridisation, we found that
PBMC isolated from 22 control individuals using
 .Ficoll-Paque Pharmacia had 0.9"0.06 copies total
 .APP mRNArpg DNA ns21 , compared to 1.79"
0.17 copiesrpg DNA in the control lymphoblasts
 .included in the present study ns9 . Activation of
T-lymphocytes increases APP expression, an increase
which is associated with lymphocyte entry into the
w xcell cycle 37,42,43 and is due to APP mRNA
stabilisation by cytosolic proteins which bind to 3X
w xuntranslated regions 43 . These findings help explain
why the APP mRNA levels detected in the dividing
lymphoblasts in the present study were higher than
those present in freshly isolated PBMC. The major
form of APP detected in the lymphoblastoid cell lines
contained the KPI insert, in agreement with previous
w xstudies of PBMC 38,39 . We did not differentiate
between APP isoforms containing and lacking exon
 .15 L-APP in this study, although L-APP, detected
primarily in immunocompetent cells, is reported to
account for approximately 30% of total APP mRNA
w xin activated lymphocytes 39 .
In summary, APP mRNA and cell-associated full
length APP protein levels increased in a reversible
manner in lymphoblastoid cell lines following heat
shock. The APP heat shock response was not affected
in cell lines derived from individuals with Alzheimer’s
disease caused by the presence of several different
PS-1 mutations. These findings indicate that the re-
ported effects of the PS-1 mutations on APP process-
ing do not interfere with the initiation or reversal of
the normal APP response to stress such as heat shock.
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